ז'בלור

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

VINFLUNINE DITARTRATE

Mevcut itibaren:

PERRIGO ISRAEL AGENCIES LTD

ATC kodu:

L01CA05

Farmasötik formu:

תרכיז להכנת תמיסה לאינפוזיה

Kompozisyon:

VINFLUNINE DITARTRATE 25 MG/ML

Uygulama yolu:

תוך-ורידי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

PIERRE FABRE MEDICAMENT PRODUCTION, FRANCE

Terapötik grubu:

VINFLUNINE

Terapötik alanı:

VINFLUNINE

Terapötik endikasyonlar:

Javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinium-containing regimen. Efficacy and safety of vinflunine have not been studied in patients with Performance Status ?2.

Yetkilendirme tarihi:

2017-08-31